Development
Dyne Therapeutics, Inc.
DYN
$11.59
$1.1210.70%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -235.94M | -208.13M | -189.30M | -176.70M | -168.10M |
| Total Depreciation and Amortization | 1.67M | 1.68M | 1.64M | 1.67M | 1.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.80M | 18.17M | 16.83M | 16.77M | 18.15M |
| Change in Net Operating Assets | 26.31M | 5.93M | -3.72M | 8.45M | -5.38M |
| Cash from Operations | -188.16M | -182.34M | -174.55M | -149.81M | -153.65M |
| Capital Expenditure | -729.00K | -1.17M | -1.89M | -1.90M | -3.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 84.04M | 77.52M | 117.07M | 118.30M | 90.27M |
| Cash from Investing | 83.31M | 76.35M | 115.19M | 116.40M | 87.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 54.32M | 91.38M | 90.99M | 66.19M | 37.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 54.32M | 91.38M | 90.99M | 66.19M | 37.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.53M | -14.61M | 31.64M | 32.77M | -29.05M |